Dr. Krishna Singh, Associate Professor in the Department of Medical Biophysics at Western University, Canada, highlighted the vital role of breast cancer–associated genes in cardiovascular health during a special lecture at Banaras Hindu University (BHU) on Friday.
BRCA Genes and Their Role in the Heart
As reported by TOI, explaining his research, Dr. Singh noted that BRCA1, a well-known breast cancer gene, is essential for normal heart function. Meanwhile, BRCA2 contributes significantly to lipid regulation, inflammation, and the development of coronary artery disease. He added that BRCA2 also influences cardiomyocyte apoptosis and plays a role in heart attack risk.
Breakthrough in Cardiovascular Disease Research
Drawing from his research findings, Dr. Singh emphasized that this discovery marks a major step toward understanding the molecular basis of cardiovascular diseases. Importantly, it could pave the way for developing innovative therapeutic strategies to prevent and treat heart conditions in the future.
Academic and Research Journey
Dr. Singh began his academic journey at BHU before earning his MSc in Biotechnology from Goa University. He later completed a PhD in Molecular Medicine at Hannover Medical School, Germany, followed by a postdoctoral fellowship in the Department of Surgery at the University of Toronto. Throughout his career, his research has focused on uncovering the molecular mechanisms underlying cardiovascular diseases and identifying new therapeutic targets.
Contributions and Recognitions
With over 100 publications in leading journals such as Nature Communications, The Journal of Biological Chemistry, Human Mutation, and Aging Cell, Dr. Singh has made significant contributions to the field. His work has earned him prestigious honors, including the Vivian Thomas Young Investigator Award from the American Heart Association and the National New Investigator Award from the Heart and Stroke Foundation of Canada.
Research Funding and Support
Dr. Singh’s groundbreaking research has received funding from renowned organizations, including the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada, further underscoring the impact and credibility of his scientific work.